Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 87c

November 4, 2021 5:05 PM EDT

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of ($0.85), $0.87 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $103.6 million versus the consensus estimate of $138.25 million.

As of September 30, 2021, excluding restricted cash, the Company had approximately $939.5 million in cash, cash equivalents... More